Chromogranin positive cells in colorectal carcinoma and transitional mucosa
- PMID: 7560204
- PMCID: PMC502804
- DOI: 10.1136/jcp.48.8.754
Chromogranin positive cells in colorectal carcinoma and transitional mucosa
Abstract
Aims: Immunostaining of chromogranin identifies gastrointestinal mucosal endocrine cells. The detailed distribution and significance of chromogranin positive cells in colorectal carcinomas and in transitional mucosa remain unclear. The aim of this study was to clarify these aspects.
Methods: The distribution of chromogranin positive cells was studied by immunohistochemical methods in normal epithelium remote from carcinoma, in transitional mucosa, and in carcinomas of the colorectum. In selected cases northern or western blot analyses were performed.
Results: Chromogranin positive cells were seen in the lower third of the normal crypts and less frequently in transitional mucosa. Thirty five per cent (n = 38) of colorectal carcinomas showed immunohistochemically positive carcinoma cells in the tumour tissue. Northern and western blot analyses showed similar results. There was no difference in clinicopathological factors, including prognosis, between chromogranin positive cases of colorectal carcinoma (n = 38) and chromogranin negative cases (n = 70).
Conclusions: Neuroendocrine cell differentiation is controlled in transitional mucosa and the presence of chromogranin positive cells in carcinoma tissue does not influence the patient's prognosis.
Similar articles
-
Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma.Cancer Res. 1993 Jun 15;53(12):2919-26. Cancer Res. 1993. PMID: 8504433
-
Endocrine cells in colorectal carcinomas. Immunohistochemical study.Pol J Pathol. 2000;51(3):127-36. Pol J Pathol. 2000. PMID: 11247395
-
Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.Tumori. 2003 Jan-Feb;89(1):49-53. doi: 10.1177/030089160308900111. Tumori. 2003. PMID: 12729362
-
The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer.Jpn J Surg. 1991 May;21(3):253-61. doi: 10.1007/BF02470943. Jpn J Surg. 1991. PMID: 1857029 Review.
-
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.Prostate Suppl. 1998;8:43-51. Prostate Suppl. 1998. PMID: 9690663 Review.
Cited by
-
Dual regulatory role for phosphatase and tensin homolog in specification of intestinal endocrine cell subtypes.World J Gastroenterol. 2012 Apr 14;18(14):1579-89. doi: 10.3748/wjg.v18.i14.1579. World J Gastroenterol. 2012. PMID: 22529686 Free PMC article.
-
Prevalence and Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas.Endocr Pathol. 1998 Spring;9(1):35-42. doi: 10.1007/BF02739950. Endocr Pathol. 1998. PMID: 12114660
-
Rapid four-month growth of an early-stage adenocarcinoma of the colon with neuroendocrine characteristics.Dig Dis Sci. 2003 Feb;48(2):295-8. doi: 10.1023/a:1021923325881. Dig Dis Sci. 2003. PMID: 12643605 No abstract available.
-
Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.World J Gastroenterol. 2015 Nov 7;21(41):11740-7. doi: 10.3748/wjg.v21.i41.11740. World J Gastroenterol. 2015. PMID: 26556999 Free PMC article. Review.
-
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas.Virchows Arch. 2010 Nov;457(5):521-7. doi: 10.1007/s00428-010-0967-8. Epub 2010 Sep 2. Virchows Arch. 2010. PMID: 20812018
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical